- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06762886
Aerobic Exercises Versus Laser Puncture on Immune Response Following Neck Lymph Node Dissection
Aerobic Exercises Versus Laser Puncture Therapy on Immune Response Following Neck Lymph Node Dissection
Group (1): Twenty cases with decreased white blood cell counts after neck lymph nodes and deficient in blood immunological functions made up this group. They underwent aerobic exercise training on a cycle ergometer. The cases received one 15-minute session, three sessions per week, for two months, with follow-up after the course of treatment.
Group (2): Twenty cases with underdeveloped blood immune systems; decreased white blood cell counts after having their neck lymph nodes removed, a low-level laser puncture was performed on the Governing Vessel 14 acupuncture point. They received a 15-minute session, three sessions per week, for two months, with follow-up after the course of treatment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inclusion criteria:
All cases were checked carefully by a physician before the study procedures. All cases were approximately the same age. All cases were conscious. All cases in both groups obtained the same medications and they received three sessions per week for 2 months. All patients enrolled in the study had a deficiency in blood immune functions post neck lymph node dissection and received chemotherapy.
Exclusion criteria:
Patients with associated disease (other pathological conditions), patients suffering from metastases, patients taking medications that alter leukocytes count and pregnancy or epilepsy.
Measurement procedures:
The total number of circulating leukocytes (white blood cells) and the differential lymphocyte count were adopted in the current academic work to measure the immunological response in both groups. These were carried out two months after the start of treatment and before the first session: pre-treatment application and post-treatment after two months. The measurement steps were as follows:
Measurement of immune response:
The cases were seated when immune response was measured. Morning peripheral blood sample aspiration was followed by venous blood collection into sterile glass containers with the necessary anticoagulants and preservatives. A Coulter hematology analyzer (Coulter Electronics, USA) was used to perform differential counts of lymphocytes and the total leukocyte count.
Treatment procedures: The following steps were adopted to complete the treatment procedures: When a patient comes in for treatment, they were given a thorough explanation of the procedures' goals as well as their physiological and therapeutic advantages.
Cycle ergometer treatment protocol (Group 1):
The case was lying back in a comfortable position on the stationary bike ergometer when the exercise test was conducted. The exercise test began with a 3-minute warm-up session of unloaded cycling on a cycle ergometer, and then progressed at a rate of 10 W per minute up to the subject's threshold. After cycling for 30 W to warm up, the intensity was raised by 15 W every 60 seconds until fatigue, after which the individuals cycled for 30 W to cool down. This treatment protocol was administered to each patient 3 times/week for a total of 15 minutes of treatment, broken into intervals of two to three minutes each.
Low-level laser treatment protocol (Group 2):
The laser probe was administered using the contact approach on the dorsal midline, in the depression below the spinous process of C7 at Governor Vessel, with the patient seated in a chair with back support (GV - 14 Dazhui). The primary power switch was activated. The following settings were used for applying laser puncture: 5 mW, the maximum average power. Type of laser: gallium arsenide (Ga-As), 904 nm wavelength, 5 kHz maximum repetition rate - Program: Maintaining programs for people who had their neck lymph nodes removed and have a low leukocyte count, up to 30 J/cm2 of energy, a 2 J/cm2 energy density, and protective glasses were required to prevent irreversible eye injury from either direct or indirect laser exposure. The treatment took place for 15 minutes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt
- Cairo university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All cases were checked carefully by a physician before the study procedures. All cases were approximately the same age.
All cases were conscious. All cases in both groups obtained the same medications and they received three sessions per week for 2 months.
All patients enrolled in the study had a deficiency in blood immune functions post neck lymph node dissection and received chemotherapy.
Exclusion Criteria:
- Patients with associated disease (other pathological conditions). patients suffering from metastases. patients taking medications that alter leukocytes count and pregnancy or epilepsy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cycle ergometer treatment protocol (Group 1):
Twenty cases with decreased white blood cell counts after neck lymph nodes and deficient in blood immunological functions made up this group.
They underwent aerobic exercise training on a cycle ergometer.
The cases received one 15-minute session, three sessions per week, for two months, with follow-up after the course of treatment
|
The case was lying back in a comfortable position on the stationary bike ergometer when the exercise test was conducted.
The exercise test began with a 3-minute warm-up session of unloaded cycling on a cycle ergometer, and then progressed at a rate of 10 W per minute up to the subject's threshold.
After cycling for 30 W to warm up, the intensity was raised by 15 W every 60 seconds until fatigue, after which the individuals cycled for 30 W to cool down.
This treatment protocol was administered to each patient 3 times/week for a total of 15 minutes of treatment, broken into intervals of two to three minutes each.
|
|
Experimental: Low-level laser treatment protocol (Group 2):
Twenty cases with underdeveloped blood immune systems; decreased white blood cell counts after having their neck lymph nodes removed, a low-level laser puncture was performed on the Governing Vessel 14 acupuncture point.
They received a 15-minute session, three sessions per week, for two months, with follow-up after the course of treatment
|
The laser probe was administered using the contact approach on the dorsal midline, in the depression below the spinous process of C7 at Governor Vessel, with the patient seated in a chair with back support (GV - 14 Dazhui).
The primary power switch was activated.
The following settings were used for applying laser puncture: 5 mW, the maximum average power.
Type of laser: gallium arsenide (Ga-As), 904 nm wavelength, 5 kHz maximum repetition rate - Program: Maintaining programs for people who had their neck lymph nodes removed and have a low leukocyte count, up to 30 J/cm2 of energy, a 2 J/cm2 energy density, and protective glasses were required to prevent irreversible eye injury from either direct or indirect laser exposure.
The treatment took place for 15 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leukocyte total count and differential lymphocyte count measurements
Time Frame: 2 months
|
Measurement of immune response: The cases were seated when immune response was measured. Morning peripheral blood sample aspiration was followed by venous blood collection into sterile glass containers with the necessary anticoagulants and preservatives. A Coulter hematology analyzer (Coulter Electronics, USA) was used to perform differential counts of lymphocytes and the total leukocyte count. |
2 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P.T.REC/012/004069
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Immune Defects
-
National Institute of Allergy and Infectious Diseases...University of South Florida; University of MiamiRecruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Septal Defects, Atrial | Heart Septal Defects, Ventricular | Endocardial Cushion Defects | Defect, Congenital Heart
-
Oslo University HospitalUniversity of BergenCompletedHeart Septal Defects, Atrial | Heart Defects,CongenitalNorway
-
Sohag UniversityRecruitingReconstruction of Head Soft Tissue Defects | Reconstruction of Neck Soft Tissue DefectsEgypt
-
Oslo University HospitalBioPhausiaCompletedHeart Defects, Congenital | Transposition of Great Vessels | Heart Septal Defects, Ventricular | Endocardial Cushion Defects
-
SeptRx, Inc.UnknownHeart Septal Defects | Heart Defects, Congenital | Foramen Ovale, PatentGermany, France
-
University of UtahTerminatedAtrial Septal Defect | Patent Foramen Ovale | Allergic Reaction to NickelUnited States
-
Nationwide Children's HospitalCompletedTetralogy of Fallot (TOF) | Ventricular Septal Defects (VSD) | Atrioventricular Septal Defects (AVSD)United States
-
Postgraduate Institute of Dental Sciences RohtakPost Graduate Institute of Dental SciencesNot yet recruitingApicomarginal DefectsIndia
Clinical Trials on Cycle ergometer
-
Lahore University of Biological and Applied SciencesNot yet recruitingPregnancy Complications | Gestational Diabetes Mellitus (GDM) | Diabetes During Pregnancy | Pregnancy in Diabetes | Gestational | Diabetes ComplicationPakistan
-
Lakehead UniversityNorthern Ontario School of MedicineCompletedOsteoarthritis | Deep Venous ThrombosisCanada
-
Zhujiang HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)China
-
Universidade da CoruñaCompleted
-
Turku University HospitalUnknownGlymphatic System | NeurodegenerationFinland
-
Universitätsklinikum Hamburg-EppendorfRecruitingMetastatic MelanomaGermany
-
Riphah International UniversityCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IPakistan
-
University of Sao PauloWithdrawnCardiac Surgery | Exercise Movement TechniquesBrazil
-
Brennan ThompsonWithdrawnPost Activation PotentiationUnited States
-
Hospital de Clinicas de Porto AlegreCompleted